Consumer Fraud Articles

Investment and securities fraud is one area of consumer fraud litigation pursued by the attorneys at Beasley Allen. Litigation includes individual cases as well as class actions that have been filed throughout the country. Cases in this area also involve matters including wrongful conduct of insurance and finance companies including fraud and bad faith, mortgage loan fraud, general consumer fraud and employment issues. Pending cases include securities and investment fraud litigation against companies including Stanford Securities and Regions Morgan Keegan, among others.

Our firm also is representing people who have been taken advantage of in the workplace, through violations of the Fair Labor Standards Act (FLSA). In these cases, employers intentionally misclassify employees as independent contractors or managers in order to reduce costs such as overtime compensation, employee benefits, payroll taxes, unemployment compensation and workers compensation.

Toyota agrees to settle unintended acceleration lawsuits for $1.1 billion

Posted: December 27, 2012

Toyota Motor Corp. has agreed to pay $1.1 billion to settle class-action lawsuits related to sudden and unintentional acceleration in some of its vehicles. If approved, the settlement would be one of the largest in automotive history.

New bill restores and expands whistleblower protections to federal workers

Posted: November 28, 2012

President Obama signed a whistleblower bill into law Tuesday that makes sweeping changes to current laws by closing loopholes and offering greater protection to federal employees who blow the whistle on fraud, waste, and abuse in government operations.

Small Key West pharmacy exposes billions in health care fraud

Posted: November 12, 2012

A small pharmacy in the Florida Keys earned the distinction of being the top whistleblower in the country for its role in exposing prescription drug fraud that costs state and federal governments billions of dollars in taxpayer funds.

Healthcare fraud crackdown leads to 91 criminal charges involving $430 million

Posted: October 10, 2012

Another U.S. government crackdown on Medicare and Medicaid fraud resulted in the criminal charges against 91 health care professionals, including several doctors and nurses, for allegedly cheating the federal programs out of $430 million. The latest sweep was similar in

Government cracks down on Medicare fraud

Posted: October 8, 2012

Nearly 100 doctors, nurses and other medical professionals in seven cities across the country were criminally charged with fraudulently billing Medicare for a total of $452 million. It was the second major sweep made this year by government officials in

Drug companies pay billions to settle fraud, illegal marketing claims

Posted: October 3, 2012

More than $30 billion has been collected by federal and state prosecutors from drug companies for alleged fraud and illegal marketing over the past two decades, with the majority of those fines collected since 2009, according to a new report

Fraud settlements with drug companies amount to big return for Mississippi taxpayers

Posted: September 28, 2012

Mississippi Attorney General Jim Hood handed state lawmakers a check for more than $35 million in funds recovered by his office mainly from several cases of health care fraud committed by big-name pharmaceutical companies.

FDA warns online pharmaceutical shoppers to beware of bogus FDA agents

Posted: September 25, 2012

The Food and Drug Administration (FDA) is warning consumers who purchase medications online that they maybe become targets for criminals posing as FDA agents. These bogus “agents” are getting personal information and using it to scare consumers into thinking they

Lawsuit filed against drug maker for violating consumer protection laws

Posted: September 21, 2012

Arizona has filed a lawsuit against McKesson Corp, the nation’s largest drug wholesaler, claiming the company violated state consumer protection laws by artificially inflating the prices of more than 400 brand-name prescription drugs, including Allegra, Celebrex, Coumadin, Flonase, Lipitor and

FDA warns L’Oreal, Lancome to tone down claims for skin products

Posted: September 13, 2012

The Food and Drug Administration (FDA) is cracking down on the world’s largest cosmetics maker, telling it to tone down claims on its anti-aging creams or apply for approval through the drug review process. The agency sent a letter to